The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Interventional Cardiology Devices And Equipment Market From 2026 To 2030?
The interventional cardiology devices and equipment market size has experienced significant expansion in recent years. It is forecast to increase from $15.65 billion in 2025 to $16.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. This market’s historical growth can be attributed to factors such as the rising prevalence of cardiovascular diseases, increased adoption of minimally invasive procedures, the expansion of cardiac catheterization laboratories, improvements in stent and catheter materials, and a growing aging population.
The interventional cardiology devices and equipment market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $21.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. Key factors driving this growth during the forecast period include a rising demand for advanced interventional devices, greater integration of AI in cardiac procedures, the expansion of outpatient and mobile cardiac care services, an intensified focus on personalized patient treatments, and increased capital flowing into cardiovascular innovation. Significant trends expected over the forecast horizon encompass the wider use of drug-eluting and bioabsorbable stents, an uptick in advanced catheter-based treatments, further incorporation of imaging-guided interventional techniques, the expansion of minimally invasive heart procedures, and a heightened emphasis on accuracy and patient well-being.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2444&type=smp
What Key Factors Are Affecting The Interventional Cardiology Devices And Equipment Market Demand?
The anticipated rise in cardiovascular diseases is set to drive the expansion of the interventional cardiology devices and equipment market. Cardiovascular diseases are defined as health issues impacting the heart, circulatory system, and blood vessels. Factors such as inadequate diets, insufficient physical activity, stress, smoking, and obesity are contributing to the growing prevalence of these conditions. This escalating occurrence of cardiovascular diseases is boosting the need for interventional cardiology devices, given that a greater number of heart patients need sophisticated instruments for less invasive procedures, thereby promoting market development. As an illustration, the Australian Institute of Health and Welfare, a government agency located in Australia, reported in October 2025 that cardiovascular disease represented nearly 12 percent of the total disease burden in Australia in 2024, with figures showing 14 percent for males and 10 percent for females. Furthermore, Australians collectively lost approximately 685,000 years of healthy life, which translates to 25.5 per 1,000 population, attributable to all types of cardiovascular disease. Consequently, the expanding incidence of cardiovascular diseases will continue to stimulate the growth of the interventional cardiology devices and equipment market in the future.
Which Segment Classifications Are Used In The Interventional Cardiology Devices And Equipment Market Segment Analysis?
The interventional cardiology devices and equipment market covered in this report is segmented –
1) By Type: Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Interventional Cardiology Devices
2) By Age Group: New-born (0-30 days), Infant (31 days-1 year), Children (1-18 years), Adult (18+ years)
3) By Application: Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centers
Subsegments:
1) By Angioplasty Balloons: Normal Balloons, Drug-Eluting Balloons, Cutting Balloons
2) By Angioplasty Stents: Bare-Metal Stents (BMS), Drug-Eluting Stents (DES), Bioabsorbable Stents
3) By Catheters: Guiding Catheters, Balloon Catheters, Angiography Catheters
4) By Plaque Modification Devices: Atherectomy Devices, Thrombectomy Devices
5) By Other Interventional Cardiology Devices: Guidewires, Vascular Closure Devices, Inflation Devices
What Trends Are Influencing Changes In The Interventional Cardiology Devices And Equipment Market?
Leading firms within the interventional cardiology devices and equipment market are prioritizing advanced technological solutions, such as percutaneous transluminal coronary angioplasty (PTCA), to address the increasing need for less invasive methods in managing cardiovascular conditions. The percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter, incorporating Twin-Wall technology, offers an advanced answer for handling complex coronary lesions. A notable example is the introduction in February 2023 by SIS Medical AG, a medical company based in Switzerland, of the OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter, also featuring Twin-Wall technology. This product represents an advanced balloon catheter engineered for enhanced efficacy in difficult coronary blockages. The OPN NC percutaneous transluminal coronary angioplasty (PTCA) catheter is capable of enhancing patient results for individuals suffering from coronary artery disease.
Which Firms Are Contributing To The Interventional Cardiology Devices And Equipment Market Ecosystem?
Major companies operating in the interventional cardiology devices and equipment market are GE Healthcare, Abbott Laboratories, Boston Scientific Corporation, Medtronic Inc., Johnson & Johnson, B. Braun Melsungen AG, Biosensors International Ltd, Cook Medical LLC, Biotronik SE & Co. KG, ACIST Medical Systems Inc., Cordis Corporation, Terumo Corporation, Cardinal Health Inc., iVascular GmbH, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, C. R. Bard Inc., Endologix Inc., Lombard Medical Limited, Spectranetics Corporation, Vascular Solutions Inc., W. L. Gore & Associates Inc., Cardiva Medical Inc., Cardiovascular Systems Inc., ClearStream Technologies Ltd., Contego Medical LLC, Shockwave Medical Inc.
Get The Full Interventional Cardiology Devices And Equipment Market Report:
Which Region Is The Leading Market For The Interventional Cardiology Devices And Equipment Market?
North America was the largest region in the global interventional cardiology devices and equipment market in 2025. Western Europe was the second-largest region in the interventional cardiology devices and equipment market. The regions covered in the interventional cardiology devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Interventional Cardiology Devices And Equipment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=2444&type=smp
Browse Through More Reports Similar to the Global Interventional Cardiology Devices And Equipment Market 2026, By The Business Research Company
Neuromodulation Market Report 2026
https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report
Internal Neuromodulation Devices Market Report 2026
Neurostimulation Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model